A comparative study of efficacy of intramuscular PGF2alpha and intramuscular oxytocin in management of third stage of labour

Authors

  • Manju Agarwal Department of Obstetrics and Gynecology, Jhalawar Medical College, Jhalawar, Rajasthan, India
  • Saroj Kumari Meena Department of Obstetrics and Gynecology, Jhalawar Medical College, Jhalawar, Rajasthan, India
  • Sushma Department of Obstetrics and Gynecology, Jhalawar Medical College, Jhalawar, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20233301

Keywords:

Active management of third stage of labour, Carboprost, Oxytocin

Abstract

Background: The third stage of labour is most crutial stage begins with expulsion of baby and end with expulsion of placenta and membranes. The present study was conducted to evaluate the scope of using prophylactic intramuscular carboprost tromethamine in comparison with intramuscular oxytocin for active management of third stage of labor.

Methods: Patients were divided randomly into 2 groups 39 in each group. Patients assigned to group 1 received 10 units oxytocin IM and group 2 received carboprost 125 µg IM after delivery of anterior shoulder of baby. The main outcomes measured were duration of third stage of labor, mean amount of blood loss, additional oxytocic requirement, HB changes in group and side effects of drug which were used in each group.

Results: Subjects who received carboprost showed a significant reduction in duration of third stage of labor (P= 0.041), amount of blood loss (P=0.046) and requirement of additional oxytocic compared to the subject who received oxytocin 10 units.

Conclusions: Carboprost 125µg is better alternative compared to injection 10 units oxytocin in the prophylactic management of third stage of labor.

 

References

Dutta DC. Normal Labour. Textbook of Obstetrics. 10th ed. Jaypee Brothers: Medical Publisher; 2021:132-134.

Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. Williams Obstetrics. 26th ed. McGraw Hill; 2022:1906.

World Health Organisation. WHO recommendations: uterotonics for the prevention of postpartum haemorrhage, 2018. Available at: https://www.who.int/publications/i/item/9789241550420. Accessed DD MMM YYYY.

Adewumi RR. American College of Obstetricians and Gynecologists Postpartum Hemorrhage Protocol (Doctoral dissertation, Walden University). Practice Bulletin No.183, 2017.

Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol. 1990;162(1):205-8.

Lamba A, Joshi G, Gupta M. Role of carboprost in prevention of postpartum hemorrhage. Inter J Reprod Contracep Obstet Gynecol. 2016;5(7):2151-5.

Begley CM, Gyte GM, Devane D, McGuire W, Weeks A, Biesty LM. Active versus expectant management for women in the third stage of labour. Cochr Data System Revi. 2019;11(2):CD007412.

International Confederation of Midwives, International Federation of Obstetrics and Gynecology. Prevention and reatment of post-partum hemorrhage. New advances for low resource settings. Int J Gynecol Obstet. 2007;97:160.

Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15 M) for the control of postpartum hemorrhage. Am J Perinatol. 1986;3(3):241-3.

Management of the third stage of labour to prevent post-partum haemorrhage (joint statement). The Hague and London: International Confederation of Midwives and International Federation of Gynaecology and Obstetrics, 2003.

Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, et al. Drape estimation vs visual assessment for estimating postpartum haemorrhage. IJOG. 2006;93(3):220-4.

Kamalajayaram V, Devi ED. Prophylactic PGF2a for control of postpartum bleeding a comparative study with methyl ergometrine. J Obstet Gynaecol India. 1994;44:393-7.

Anjaneyulu R, Pk D, Jain S, Cr K, Vijaya R, Ks R. Prophylactic use of 15 (5)methyl PGF2a by IM route- A controlled clinical trial. Acta Obstet Gynecol Scand Suppl. 1988;67(S145):9-11.

Madhulika DS, Rai S. Comparison of carboprost with oxytocin in third stage of labour. Inter J Clin Obstet Gynaecol. 2019;3(5):318-21.

Tuvar V, Chavda K, Chavda DA. Carboprost verses oxytocin in active manageent of third stage of labour. IJSR. 2016;7(10):1383-5.

Sunil Kumar KS, Shyam S, Batakurki P. Carboprost versus oxytocin for active management of third stage of labor: a prospective randomized control study. J Obstet Gynecol India. 2016;66(S1):229-34.

Patil AS, Dadavate V, Thobbi VA. Carboprost versus oxytocin for active management of third stage of labour. Al Ame J Med Sci. 2016;9(3):196-201.

Downloads

Published

2023-10-27

Issue

Section

Original Research Articles